Cereno Scientific presents the agenda for the upcoming Capital Markets Day to be held October 17th, 2024
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced the agenda for the Capital Markets Day that will be held on Thursday October 17, 2024.The Capital Markets Day will provide an opportunity for investors, analysts, and media to get insights into Cereno’s clinical and preclinical development portfolio and operations as well as its future growth strategy. The program includes presentations by the Cereno Executive Management Team as well as external speakers The interest for the